Loading…
Lobbying Income
—
Filings
2
Unique Clients
1
Active Period
2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Client expense: — · Firm income: —
Matched citations: H.R. 7779
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Client expense: — · Firm income: —
Matched citations: H.R. 7779
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Client expense: — · Firm income: —
Matched citations: H.R. 7779
Expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
2026 · third_quarter · Client: CUREPSP
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Client expense: — · Firm income: —
Matched citations: H.Res.1318
Expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
2026 · third_quarter · Client: CUREPSP
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Client expense: — · Firm income: —
Matched citations: H.Res.1318
Expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
2026 · third_quarter · Client: CUREPSP
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Client expense: — · Firm income: —
Matched citations: H.Res.1318
A resolution expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
2026 · third_quarter · Client: CUREPSP
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Client expense: — · Firm income: —
Matched citations: S.Res.752
A resolution expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
2026 · third_quarter · Client: CUREPSP
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Client expense: — · Firm income: —
Matched citations: S.Res.752
A resolution expressing support for the designation of the month of May 2026 as "Progressive Supranuclear Palsy and Corticobasal Degeneration Awareness Month".
2026 · third_quarter · Client: CUREPSP
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Client expense: — · Firm income: —
Matched citations: S.Res.752
Source: Senate LDA